KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $16.85 Thursday, 25th Apr 2024 URGN stock ended at $13.82. This is 2.74% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.30% from a day low at $13.77 to a day high of $14.50.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Jan 08, 2024 $13.84 $14.58 $13.68 $14.56 108 695
Jan 05, 2024 $13.89 $13.90 $13.40 $13.81 171 655
Jan 04, 2024 $14.10 $14.49 $13.84 $14.09 168 478
Jan 03, 2024 $15.33 $15.33 $13.95 $14.02 258 269
Jan 02, 2024 $14.97 $15.48 $14.80 $15.21 249 241
Dec 29, 2023 $15.21 $15.30 $14.75 $15.00 296 758
Dec 28, 2023 $14.46 $15.06 $14.40 $15.06 435 546
Dec 27, 2023 $14.36 $14.64 $14.28 $14.40 138 052
Dec 26, 2023 $14.67 $14.67 $14.26 $14.44 303 466
Dec 22, 2023 $15.15 $16.10 $14.39 $14.50 296 642
Dec 21, 2023 $14.90 $15.14 $14.87 $15.07 97 768
Dec 20, 2023 $15.08 $15.55 $14.74 $14.87 143 464
Dec 19, 2023 $15.15 $16.21 $14.92 $15.10 153 212
Dec 18, 2023 $15.00 $15.24 $14.57 $15.01 159 884
Dec 15, 2023 $15.38 $15.86 $14.83 $15.00 1 427 479
Dec 14, 2023 $16.20 $16.32 $15.04 $15.24 232 820
Dec 13, 2023 $14.99 $16.03 $14.95 $15.93 373 335
Dec 12, 2023 $14.20 $15.11 $14.15 $15.05 206 623
Dec 11, 2023 $14.35 $14.39 $13.93 $14.25 140 016
Dec 08, 2023 $14.37 $14.61 $13.93 $14.27 143 357
Dec 07, 2023 $13.39 $14.53 $13.27 $14.44 225 790
Dec 06, 2023 $13.25 $13.65 $13.22 $13.42 185 310
Dec 05, 2023 $13.31 $13.59 $13.18 $13.23 124 703
Dec 04, 2023 $13.02 $13.34 $12.93 $13.33 120 396
Dec 01, 2023 $13.25 $13.25 $12.76 $13.03 226 851
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT